Market Tracker

04/16 5:15pm ET

Novavax Inc (NASDAQ:NVAX)

During the Trading Day
4.05 +0.36 / +9.76%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
4.03 -0.02 / -0.49%
 
Volume: 15.8K

Today’s Trading

Previous close3.69
Today’s open3.75
Day’s range3.75 - 4.06
Volume3,657,297
Average volume (3 months)4,916,136
Market cap$844.6M
Dividend yield--
Data as of 3:59pm ET, 04/16/2014

Growth & Valuation

Earnings growth (last year)-40.91%
Earnings growth (this year)+4.52%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-5.26%
P/E ratioNM
Price/Sales41.53
Price/Book4.15

Competitors

 Today’s
change
Today’s
% change
SZYMSolazyme Inc+0.48+4.38%
FMIFoundation Medicine ...+2.17+8.69%
HALOHalozyme Therapeutic...+0.16+2.17%
RLYPRelypsa Inc+0.75+3.42%
Data as of 3:59pm ET, 04/16/2014

Financials

Next reporting dateMay 12, 2014
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$20.9M
Annual profit (last year)-$52.0M
Net profit margin-248.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Chief Financial Officer, Treasurer &
SVP
Barclay A. Phillips
Corporate headquarters
Rockville, Maryland

Forecasts